Three main driver gene mutations, Janus kinase 2 (JAK2), Thrombopoietin receptor (MPL) and Calreticulin (CALR), have been identified in association with MPN and may have an important role in assisting the diagnosis of MPN [4]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.